Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) Net Margin (2020 - 2025)

GeneDx Holdings has reported Net Margin over the past 6 years, most recently at 14.6% for Q4 2025.

  • Quarterly results put Net Margin at 14.6% for Q4 2025, down 2029.0% from a year ago — trailing twelve months through Dec 2025 was 4.91% (up 1221.0% YoY), and the annual figure for FY2025 was 4.92%, up 1220.0%.
  • Net Margin for Q4 2025 was 14.6% at GeneDx Holdings, down from 6.5% in the prior quarter.
  • Over the last five years, Net Margin for WGSWW hit a ceiling of 75.8% in Q3 2021 and a floor of 503.21% in Q4 2022.
  • Median Net Margin over the past 5 years was 43.14% (2023), compared with a mean of 84.97%.
  • Biggest five-year swings in Net Margin: tumbled -43369bps in 2022 and later surged 45830bps in 2023.
  • GeneDx Holdings' Net Margin stood at 69.52% in 2021, then crashed by -624bps to 503.21% in 2022, then soared by 91bps to 44.91% in 2023, then soared by 113bps to 5.69% in 2024, then tumbled by -357bps to 14.6% in 2025.
  • The last three reported values for Net Margin were 14.6% (Q4 2025), 6.5% (Q3 2025), and 10.48% (Q2 2025) per Business Quant data.